What the business is, and whether it's a good one at a fair price.
A Healthcare Services company listed on NSE and BSE, reporting revenue of ₹57 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from LOTUS EYE HOSP & INST L's filed financials and exchange disclosures
LOTUS EYE HOSP & INST L is a Healthcare Services company listed on NSE and BSE, trading under the symbol LOTUSEYE.
Yes. Over the trailing twelve months LOTUS EYE HOSP & INST L reported a net profit of ₹0 Cr on revenue of ₹57 Cr.
Yes. It paid out 15% of its profit as dividend in FY26.
No. Debt stands at 0.19× equity, and it carries net debt of ₹10 Cr. That is lower than 57% of its 24 Hospital peers.
On trailing P/E, LOTUS EYE HOSP & INST L ranks 30 of 30 in Hospital — cheaper than 0% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session LOTUS EYE HOSP & INST L moves 1.56% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by LOTUS EYE HOSP & INST L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
